klacid 50 mg/ ml
mylan healthcare norge as - klaritromycin - granulat til mikstur, suspensjon - 50 mg/ ml
zolpidem aurobindo 10 mg
aurobindo pharma (malta) limited - zolpidemtartrat - tablett, filmdrasjert - 10 mg
zolpidem aurobindo 5 mg
aurobindo pharma (malta) limited - zolpidemtartrat - tablett, filmdrasjert - 5 mg
sumatriptan teva 50 mg
teva sweden ab - sumatriptansuksinat - tablett, filmdrasjert - 50 mg
sumatriptan teva 100 mg
teva sweden ab - sumatriptansuksinat - tablett, filmdrasjert - 100 mg
dimethyl fumarate accord
accord healthcare s.l.u. - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
kolkisin tiofarma 0.5 mg
tiofarma b.v. - kolkisin - tablett - 0.5 mg
adcetris
takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - antineoplastiske midler - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.
angiox
the medicines company uk ltd - bivalirudin - akutt koronarsyndrom - antithrombotic agents - angiox er indisert som antikoagulant hos voksne pasienter som gjennomgår perkutan koronar intervensjon (pci), inkludert pasienter med st-segment-forhøyet myokardinfarkt (stemi) under primær pci. angiox er også indisert for behandling av voksne pasienter med ustabil angina / ikke-st-segment-elevation myocardial infarction (ua / nstemi) planlagt for påtrengende eller tidlig intervensjon. angiox bør administreres med acetylsalisylsyre og klopidogrel.
ecalta
pfizer europe ma eeig - anidulafungin - candidiasis - antimykotika for systemisk bruk - behandling av invasiv candidiasis i voksne og paediatric pasienter i alderen 1 måned til < 18 år.